These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 846677)

  • 1. Antihypertensive effect of indapamide.
    Gragnoli G; Puccetti F; Nami R; Tanganelli I; Favilli R; Betti E
    Minerva Med; 1977 Mar; 68(12):749-60. PubMed ID: 846677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Controlled multicentric trial of the antihypertensive agent indapamide].
    Gragnoli G; Abate G; Guerrini M
    Minerva Med; 1977 Nov; 68(54):3669-80. PubMed ID: 339132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive action of indapamide in hypertension of chronic renal failure].
    Meyrier A; Condamin MC
    Ann Cardiol Angeiol (Paris); 1994 Jan; 43(1):43-8. PubMed ID: 8172477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cicletanine tolerance in hypertensive patients with metabolic disorders].
    Passa P
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():135-8. PubMed ID: 2514653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indapamide in the treatment of essential arterial hypertension in the elderly.
    Van Hee W; Thomas J; Brems H
    Postgrad Med J; 1981; 57 Suppl 2():29-33. PubMed ID: 7033944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long term therapy of essential hypertension with indapamide: studies on the effect on electrolyte balance and glucose metabolism].
    Zorn J
    Fortschr Med; 1980 Dec; 98(46):1836-40. PubMed ID: 7274922
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-invasive cardiovascular assessment of indapamide in patients with essential hypertension.
    Dunn FG; Hillis WS; Tweddel A; Rae AP; Lorimer AR
    Postgrad Med J; 1981; 57 Suppl 2():19-22. PubMed ID: 7322955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antihypertensive action of indapamide: results of a French multicentre study of 2,184 ambulant patients.
    Mimran A; Zambrowski JJ; Coppolani T
    Postgrad Med J; 1981; 57 Suppl 2():60-3. PubMed ID: 6119686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre open trial indapamide in general practice.
    Bowker CH; Murphy MA
    Postgrad Med J; 1981; 57 Suppl 2():53-6. PubMed ID: 7033948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of indapamide 1.5 mg, sustained release, in the lowering of systolic blood pressure.
    London GM
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S9-S14. PubMed ID: 15592572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
    Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
    Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study.
    Akram J; Sheikh UE; Mahmood M; Donnelly R
    Curr Med Res Opin; 2007 Dec; 23(12):2929-36. PubMed ID: 17931463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of indapamide in resistant hypertensive therapy.
    Dean S
    Postgrad Med J; 1981; 57 Suppl 2():26-8. PubMed ID: 6119685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the pharmacology and clinical efficacy of indapamide sustained release.
    Sassard J; Bataillard A; McIntyre H
    Fundam Clin Pharmacol; 2005 Dec; 19(6):637-45. PubMed ID: 16313275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systemic hemodynamic evaluation of indapamide.
    Gensini G; Esente P; Giambartolomei A
    Clin Ther; 1983; 5(5):475-82. PubMed ID: 6616523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
    Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H
    Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of indapamide 1.5 mg sustained release coated tablets in the therapy of arterial hypertension].
    Asmar R
    Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):94-104. PubMed ID: 9772936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive therapy in diabetic patients. The use of indapamide.
    Harrower AD; McFarlane G
    Am J Med; 1988 Jan; 84(1B):89-91. PubMed ID: 3277423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.